Welcome to the web-presentation of
K-BIO Institute for Cellbiotechnology and Immunology GmbH
Leader in immunological research and development(R&D) of active autologous cancer immunotherapy AHICE, for cancer after-care, as also against auto-immune-diseases, and for prevention as well. AHICE uses the complex totality of immune response working substances, targeted selective against the recognized altered body cells pathologically, autologous synthesised.
PRODUCTS AND SERVICES
Active autologous cancer immunotherapy, autologous cancer vaccine AHICE, targeted against
► differentiated body-cells pathologically (e.g. cancer, auto-immune diseases etc.) basically,
► for cancer-after-care, and for
Special case 2
immunotherapy ahice of peritoneal-cancer
Special case 3
Immunotherapy AHICE of Colon Cancer
Special case 4
immunotherapy ahice of pancreatic cancer
Special case 5
Immunotherapy of Breast Cancer
Advanced training seminars.
1. Introductory seminar in aseptic aseptic work, clean room, cell cultures,
2. Aseptic pharmaceutical processing for use on humans, good manufacturing practice GMP guideline rules / EC, German drug and active ingredient manufacturing regulation AMWHV, theory and practice.
Dates on request → contact
back → Home, Language next → Autologous Vaccine AHICE